Oxford Biomed.

Oxford Biomedica (OXB)

Company name:Oxford Biomed.
EPIC:OXBTrading Currency:GBX
Market Sector:SSC5ISIN:GB0006648157
Market Segment:SSMMShare Type:DE
WWW Address:http://www.oxfordbiomedica.co.uk/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 12.02 uk.advfn.com/p.php?gfx=/gb/up 0.2 [1.69] 12.00 12.04 11.88 12.30 11.54 5,503,073
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 394.70 3,283.69 0.01 -0.29 - - - 13.04 - 4.44

Oxford Biomedica Key Figures

(at previous day's close)
Market Cap.394.70m
Shares In Issue3,283.69m
Prev. Close11.82
PE Ratio- 
Dividend Yield-%
EPS - basic-0.29p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.09p
Return On Equity (ROE)-146.71%
Operating Margin-31.29%
PEG Factor- 
EPS Growth Rate51.67%
Dividends PS Growth Rate-%
Net Debt44.93m
Gross Gearing90.60%
Quick Assets33.65m
Net Working Capital15.22m
Intangibles / Fixed Assets0.34%
Turnover PS1.14p
Pre-Tax Profit PS-0.36p
Retained Profit PS-0.27p
Cash PS0.44p
Net Cash PS-0.23p
Net Tangible Asset Value PS *0.18p
Net Asset Value PS0.19p
Spread0.04 (0.33%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Oxford Biomedica Balance Sheet

LSE:OXB:Liabilities+EQLSE:OXB:Assets

Share Price Performance

Sample Period †HighLow
1 week12.3011.28
4 weeks12.3010.22
12 weeks13.049.75
1 year13.044.44

Share Price Chart (5 years)

Oxford Biomedica Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week11.780.242.0411.285.2411.54
4 weeks11.660.363.0910.226.3211.19
12 weeks11.540.484.169.756.6711.64
26 weeks8.883.1435.368.306.6110.66
1 year4.857.17147.844.447.799.41
3 years11.500.524.523.004.767.85
5 years1.6410.39635.171.333.987.30
† periods calculated are whole weeks rather than calendar months

Oxford Biomedica Key Management Ratios

Oxford Biomedica Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio120.63 
PE Ratio- 
Tobin's Q Ratio 6.45 
Tobin's Q Ratio (excl. intangibles)6.53 
Dividend Yield-%
Market-to-Book Ratio64.22 
Price-to-Pre-Tax Profit PS-33.56 
Price-to-Retained Profit PS-43.77 
Price-to-Cash Flow PS132.49 
Price-to-Sales PS10.50 
Price-to-Net Tangible Asset Value PS65.25 
Price-to-Cash PS27.55 
Net Working Capital PS0.46 
Price Pct to Working Capital PS25.93%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Oxford Biomedica Financial Ratios

(Leverage Ratios)
Debt Ratio85.92%
Debt-to-Equity Ratio6.10 
Debt-to-Equity Ratio (excl. Intgbl)6.20 
Debt-to-Equity Market Value0.09 
Net Gearing68.69%
Net Gearing (excl. Intangibles)68.80%
Gross Gearing90.60%
Gross Gearing (excl. Intangibles)90.74%
Gearing Under 1 Year33.27%
Gearing Under 1 Year (excl. Intgbl)33.32%
Assets/Equity10.64 
Cash/Equity233.14 
(Liquidity Ratios)
Net Working Capital to Total Assets23.27%
Current Ratio1.70 
Quick Ratio (Acid Test)1.55 
Liquidity Ratio0.66 
Cash & Equiv/Current Assets38.75%
(Solvency Ratios)
Enterprise Value417.86m
CFO/Sales0.08 
CFO/Attributable Profit- 
CFO/Assets0.05 
CFO/Debt0.05 
Total Debt/Equity Market Value0.15 
Total Debt/Sales1.58 
Total Debt/Pre-Tax Profit-5.04 
Total Debt59.26m
Total Debt/Net Current Assets3.89%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-17.15%
5 yr Compound Earnings Growth-18.16%
10 yr Compound Earnings Growth-17.14%
Earn drops > 5% in 10yrs8 
Beta (60-Mnth)Beta (36-Mnth)
0.00510.0021

Oxford Biomedica Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-26.95%
Return On Assets (ROA)-14.74%
Net Profit Margin-23.99%
Assets Turnover0.61 
Return On Equity (ROE)-146.71%
Return On Investment (ROI)-19.76%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-23.99%
(Asset Utilisation Multiples)
Shareholders Equity Turnover4.01 
Fixed Assets Turnover1.30 
Current Assets Turnover1.17 
Net Working Capital Turnover 
Inventory Turnover13.59 
(Other Operating Ratios)
Total Assets-to-Sales1.63 
Debtors-to-Sales38.87%
Debt Collection Period141.88Days

Oxford Biomedica Dividends

Sorry No Data Available

Oxford Biomedica Fundamentals
 31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
turnover13.62100.00%15.91100.00%27.78100.00%37.59100.00%m
pre tax profit-10.80-79.29%-16.98-106.74%-20.31-73.11%-11.76-31.29%m
attributable profit-8.66-63.60%-13.02-81.83%-16.64-59.91%-9.02-23.99%m
retained profit-8.66-63.60%-13.02-81.83%-16.64-59.91%-9.02-23.99%m
eps - basic (p)-0.43 -0.51 -0.60 -0.29 
eps - diluted (p)-0.43 -0.51 -0.60 -0.29 
dividends per share- - - - 

Oxford Biomedica Balance Sheet

 31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
LSE:OXB:Liabilities+EQLSE:OXB:AssetsLSE:OXB:Liabilities+EQLSE:OXB:AssetsLSE:OXB:Liabilities+EQLSE:OXB:AssetsLSE:OXB:Liabilities+EQLSE:OXB:Assets
 31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
ASSETS
fixed assets fixed assets8.9426.46%24.4047.05%27.5148.32%25.3738.79%m
intangibles intangibles2.116.23%1.743.36%1.332.34%0.100.15%m
fixed investments fixed investments--%--%0.661.15%2.954.52%m
current assets - other current assets - other--%--%--%--%m
stocks stocks1.414.16%2.715.22%2.203.87%3.335.09%m
debtors debtors7.1521.16%13.6526.33%9.9017.39%19.3229.54%m
cash & securities cash & securities14.2041.99%9.3618.04%15.3426.93%14.3321.91%m
TOTAL33.81100%51.85100%56.94100%65.40100%m
LIABILITIES
creditors - short creditors - short9.2327.31%13.1725.40%9.3216.36%21.7633.27%m
creditors - long creditors - long1.544.54%27.7953.59%35.0161.49%37.4957.33%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL10.7731.85%40.9678.99%44.3377.85%59.2690.60%m
EQUITY
ord cap, reserves ord cap, reserves23.0468.15%10.8921.01%12.6222.15%6.159.40%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL23.0468.15%10.8921.01%12.6222.15%6.159.40%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Oxford Biomedica Cash Flow Statement

31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
Operating CF-6.03-13.12-5.112.98m
Pre-Financing CF-11.56-29.80-11.521.05m
Retained CF12.03-4.845.98-1.01m

Oxford Biomedica Brokers

NameActivityTypeMnemonicCode
J.P. Morgan Cazenove LimitedMarket Maker(MME)Broker/DealerCAZRCAZEGB2L
Nomura Code Securities LimitedMarket Maker(MME)Broker/DealerCODECODCGB21
Collins Stewart Europe LimitedMarket Maker(MME)Broker/DealerCSCSCSTEGB21
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Panmure Gordon (UK) LimitedMarket Maker(MME)Broker/DealerPMURPMURGB2L
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:gb D:20180421 00:23:58